Hideaki Tahara

Recombinant IL-12 administration induces tumor regression in association with IFN- <i>gamma</i> production.

Chet Nastala, Howard Edington, T G McKinney et al. · The Journal of Immunology · 1994 · 792 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

Michael B. Atkins, Michael J. Robertson, Michael S. Gordon et al. · PubMed · 1997 · 590 citations

Medicine, Oncology, Pharmacology +15

Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

Masahisa Jinushi, Shigeki Chiba, Hironori Yoshiyama et al. · Proceedings of the National Academy of Sciences · 2011 · 484 citations · Full text

Medicine, Cancer Biology, Oncology +17

Expression of immunoreactive E-cadherin adhesion molecules in human cancers.

Hitoshi Shiozaki, Hideaki Tahara, Hiroshi Oka et al. · PubMed · 1991 · 381 citations

Life Sciences, Cell Biology, Oncology +10

Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

Hideaki Tahara, Herbert J. Zeh, Walter J. Storkus et al. · PubMed · 1994 · 333 citations

Life Sciences, Immunology, Oncology +17